Full Press Release Details
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).
IRD
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Key Takeaway: Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Price reaction · baseline $2.13 (2025-12-15 close) · hit after-hours · clean, no other IRD news in the window
day 0 close
+0.5%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+140%
120-day peak, hindsight
Typical move
6.3%
average across 11 past catalysts
Cash runway
~22 mo
Low dilution risk
Lead asset
APX3330
Phase 2 · Diabetic Retinopathy